Skip to main content
FTRE
NASDAQ Life Sciences

Fortrea to Acquire Early Phase Services from Worldwide Clinical Trials for $45M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$17.72
Mkt Cap
$1.685B
52W Low
$8.305
52W High
$21.39
52W Position info
113% above low
Off High info
17% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $8.305.

Summary

Fortrea is acquiring Worldwide Clinical Trials' Early Phase Services division for approximately $45M in cash. The deal adds a 60,000 sq ft GLP bioanalytical lab in Austin, a 200-bed clinical pharmacology unit in San Antonio, and a biospecimen storage facility in Pflugerville, Texas. This expands Fortrea's early clinical development capabilities, adding in-house large and small molecule bioanalytical services and increasing North American bed capacity. The acquisition follows a period of finance leadership turnover and a strong Q2 operational turnaround. The transaction is expected to close pending regulatory approvals and services agreements.

At the time of this announcement, FTRE was trading at $17.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $8.31 to $21.39. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Oct 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.14
Real-time Price: $20.20 info
Change: -$2.94 (-13%) info
Market Cap: $1.949B info
FTRE
Oct 29, 2026, 6:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $20.20 info
Change: -$5.57 (-22%) info
Market Cap: $1.949B info
FTRE
Oct 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.80
Real-time Price: $20.20 info
Change: -$5.60 (-22%) info
Market Cap: $1.949B info
FTRE
Sep 10, 2026, 8:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $20.20 info
Change: +$3.41 (+20%) info
Market Cap: $1.949B info
FTRE
Sep 10, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $20.20 info
Change: +$3.41 (+20%) info
Market Cap: $1.949B info